Recombinant pro-urokinase, like TPA, increases the chances of dangerous bleeding in the brain.
Genetically engineered microorganisms are also producing the enzyme urokinase, used to dissolve blood clots; the hormone thymosin alpha1, which shows promise as a treatment for .
Urokinase (CAS 9039-53-6) Market Research Report DUBLIN, March 20, 2014 /PRNewswire/ -- Dublin - Research and Markets (http://www.researchandmarkets.com/research/6h645z/urokinase_cas) has announced the addition of...
March 20, 2014 - PR Newswire